MARKET

SNY

SNY

Sanofi FR
NASDAQ
44.25
+0.14
+0.32%
After Hours: 44.20 -0.05 -0.11% 19:38 06/12 EDT
OPEN
44.11
PREV CLOSE
44.11
HIGH
44.51
LOW
44.02
VOLUME
1.63M
TURNOVER
--
52 WEEK HIGH
49.91
52 WEEK LOW
41.05
MARKET CAP
106.87B
P/E (TTM)
21.06
1D
5D
1M
3M
1Y
5Y
1D
FDA Grants Accelerated Approval To Sanofi's Tzield For Children With Stage 3 Type 1 Diabetes
NASDAQ · 5h ago
FDA grants accelerated approval to Sanofi Tzield for newly diagnosed stage 3 type 1 diabetes in children 8-17
PUBT · 12h ago
PRESS RELEASE: SANOFI’S TZIELD APPROVED IN THE US AS THE FIRST DISEASE-MODIFYING THERAPY FOR PATIENTS RECENTLY DIAGNOSED WITH STAGE 3 TYPE 1 DIABETES
Reuters · 12h ago
FDA: TZIELD HAS A BOXED WARNING - WEBSITE
Reuters · 13h ago
Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James
TipRanks · 15h ago
Sanofi Expands Global Employee Share Plan with 2026 Offering
TipRanks · 19h ago
Sanofi launches 2026 employee share plan with EUR 59.87 subscription price, 20% discount
PUBT · 19h ago
Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data
NASDAQ · 19h ago
More
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA (ADR) stock information, including NASDAQ: SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.